In Vitro Activity of Sparfloxacin (AT-4140), a New Quinolone Agent, Against Invasive Isolates From Pediatric Patients.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.36.2.255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Activity of Sparfloxacin (CI-978; AT-4140) Against Clinical Isolates From Cancer Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

In Vitro Activity of HSR-903, a New Quinolone.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Antistaphylococcal Activities of Sparfloxacin (CI-978; AT-4140), Ofloxacin, and Ciprofloxacin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

Comparative in Vitro Activity of a New Quinolone, AM-1091.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1989English

In Vitro Activity of Ro 23-9424, a Dual-Action Antibacterial Agent, Against Bacterial Isolates From Cancer Patients Compared With Those of Other Agents.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

Comparative In-Vitro Activity of Ceftaroline Against Staphylococcus Aureus Isolates From India

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2016English

In Vitro Activity of Amiloride Combined With Tobramycin Against Pseudomonas Isolates From Patients With Cystic Fibrosis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1988English

Comparative In-Vitro Activity of New Quinolones Against Clinical Isolates and Resistant Mutants

Journal of Antimicrobial Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
1992English

In Vitro and in Vivo Activity of NY-198, a New Difluorinated Quinolone.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy